Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer

Yasaman Anbari; Floortje E. Veerman; Grace Keane; Arthur J.A.T. Braat; Maarten L.J. Smits; Rutger C.G. Bruijnen; Wenle Tan; Ye Li; Feng Duan; Marnix G.E.H. Lam

doi:10.1016/j.jimed.2023.09.001

Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer

Yasaman Anbari^*, Floortje E. Veerman, Grace Keane, Arthur J.A.T. Braat, Maarten L.J. Smits, Rutger C.G. Bruijnen, Wenle Tan, Ye Li, Feng Duan, Marnix G.E.H. Lam

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

80 Downloads (Pure)

Abstract

Liver malignancy, including primary liver cancer and metastatic liver cancer has become one of the most common causes of cancer-related death worldwide due to the high malignant degree and limited systematic treatment strategy. Radioembolization with yttrium-90 (⁹⁰Y)-loaded microspheres is a relatively novel technology that has made significant progress in the local treatment of liver malignancy. The different steps in the extensive work-up of radioembolization for patients with an indication for treatment with ⁹⁰Y microspheres, from patient selection to follow up, both technically and clinically, are discussed in this paper. It describes the application and development of ⁹⁰Y microspheres in the treatment of liver cancer.

Original language	English
Pages (from-to)	153-159
Number of pages	7
Journal	Journal of Interventional Medicine
Volume	6
Issue number	4
DOIs	https://doi.org/10.1016/j.jimed.2023.09.001
Publication status	Published - Nov 2023

Keywords

Metastatic liver cancer
Primary liver cancer
Selective internal radiation therapy
Trans-arterial radioembolization
Yttrium-90 microspheres

Access to Document

10.1016/j.jimed.2023.09.001Licence: CC BY-NC-ND

1-s2.0-S2096360223000479-mainFinal published version, 667 KBLicence: CC BY-NC-ND

Cite this

@article{785294340ec34afaa7c509e48a74734a,

title = "Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer",

abstract = "Liver malignancy, including primary liver cancer and metastatic liver cancer has become one of the most common causes of cancer-related death worldwide due to the high malignant degree and limited systematic treatment strategy. Radioembolization with yttrium-90 (90Y)-loaded microspheres is a relatively novel technology that has made significant progress in the local treatment of liver malignancy. The different steps in the extensive work-up of radioembolization for patients with an indication for treatment with 90Y microspheres, from patient selection to follow up, both technically and clinically, are discussed in this paper. It describes the application and development of 90Y microspheres in the treatment of liver cancer.",

keywords = "Metastatic liver cancer, Primary liver cancer, Selective internal radiation therapy, Trans-arterial radioembolization, Yttrium-90 microspheres",

author = "Yasaman Anbari and Veerman, {Floortje E.} and Grace Keane and Braat, {Arthur J.A.T.} and Smits, {Maarten L.J.} and Bruijnen, {Rutger C.G.} and Wenle Tan and Ye Li and Feng Duan and Lam, {Marnix G.E.H.}",

note = "Publisher Copyright: {\textcopyright} 2023 Shanghai Journal of Interventional Radiology Press",

year = "2023",

month = nov,

doi = "10.1016/j.jimed.2023.09.001",

language = "English",

volume = "6",

pages = "153--159",

number = "4",

}

TY - JOUR

T1 - Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer

AU - Anbari, Yasaman

AU - Veerman, Floortje E.

AU - Keane, Grace

AU - Braat, Arthur J.A.T.

AU - Smits, Maarten L.J.

AU - Bruijnen, Rutger C.G.

AU - Tan, Wenle

AU - Li, Ye

AU - Duan, Feng

AU - Lam, Marnix G.E.H.

PY - 2023/11

Y1 - 2023/11

N2 - Liver malignancy, including primary liver cancer and metastatic liver cancer has become one of the most common causes of cancer-related death worldwide due to the high malignant degree and limited systematic treatment strategy. Radioembolization with yttrium-90 (90Y)-loaded microspheres is a relatively novel technology that has made significant progress in the local treatment of liver malignancy. The different steps in the extensive work-up of radioembolization for patients with an indication for treatment with 90Y microspheres, from patient selection to follow up, both technically and clinically, are discussed in this paper. It describes the application and development of 90Y microspheres in the treatment of liver cancer.

AB - Liver malignancy, including primary liver cancer and metastatic liver cancer has become one of the most common causes of cancer-related death worldwide due to the high malignant degree and limited systematic treatment strategy. Radioembolization with yttrium-90 (90Y)-loaded microspheres is a relatively novel technology that has made significant progress in the local treatment of liver malignancy. The different steps in the extensive work-up of radioembolization for patients with an indication for treatment with 90Y microspheres, from patient selection to follow up, both technically and clinically, are discussed in this paper. It describes the application and development of 90Y microspheres in the treatment of liver cancer.

KW - Metastatic liver cancer

KW - Primary liver cancer

KW - Selective internal radiation therapy

KW - Trans-arterial radioembolization

KW - Yttrium-90 microspheres

UR - http://www.scopus.com/inward/record.url?scp=85171432161&partnerID=8YFLogxK

U2 - 10.1016/j.jimed.2023.09.001

DO - 10.1016/j.jimed.2023.09.001

M3 - Article

AN - SCOPUS:85171432161

VL - 6

SP - 153

EP - 159

JO - Journal of Interventional Medicine

JF - Journal of Interventional Medicine

IS - 4

ER -

Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this